Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bevacizumab

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCMD1705

    06/12/2017

    A Phase 1B Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered with Ipilumumab, Interferon-Alpha or other Immune Modulating Therapies in Patients with Locally Advanced Metastatic Solid Tumors

    Treatment

    ECOGNEUA221208

    01/18/2017

    Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis after Radiosurgery for Brain Metastases


    Print this page for your doctor